Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.

@article{Xirouchakis2008PegylatedinterferonAR,
  title={Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.},
  author={Elias Xirouchakis and Christos Triantos and Pinelopi Manousou and A. Sigalas and Vincenza Calvaruso and Alice Corbani and Gioacchino Leandro and David W Patch and Ak Burroughs},
  journal={Journal of viral hepatitis},
  year={2008},
  volume={15 10},
  pages={
          699-709
        }
}
SUMMARY Pegylated interferon with ribavirin (Peg/R) is the most effective therapy for chronic hepatitis C virus (HCV) but its utility and effectiveness after liver transplantation has been difficult to assess. We evaluated efficacy, tolerability, and safety of Peg/R in liver transplant candidates and recipients with HCV cirrhosis. We searched medical databases and conference proceedings between January 1999 and January 2008 selecting randomized and nonrandomized studies. Primary end points meta… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 59 CITATIONS, ESTIMATED 47% COVERAGE

Recurrence of hepatitis C after liver transplantation

VIEW 19 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States

  • Allison J Kwong, W. Ray Kim, +3 authors Donghee Kim
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2009
2018

CITATION STATISTICS

  • 1 Highly Influenced Citations